October 22, 2013 | Israeli biomed company Neuroderm, which is developing a transdermal drug delivery system, is in the process of raising $5 million. “Globes” reports that the funds are being raised from current investors and new foreign investors.
The proceeds will be used to accelerate clinical trials and for a review of a possible IPO on Nasdaq in 2014.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments